药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hydralazine
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Crizotinib.
Hydralazine
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Crizotinib.
Hydralazine
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Crizotinib.
Hydralazine
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Crizotinib.
Hydralazine
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Crizotinib.
Hydralazine
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Crizotinib.
Hydralazine
Encorafenib
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Encorafenib.
Hydralazine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Dexverapamil.
Hydralazine
Penfluridol
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Penfluridol.
Hydralazine
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Dexchlorpheniramine.
Hydralazine
Lorcainide
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Lorcainide.
Hydralazine
Bunaftine
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Bunaftine.
Hydralazine
Nizofenone
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Nizofenone.
Hydralazine
Otilonium
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Otilonium.
Hydralazine
Sultopride
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Sultopride.
Hydralazine
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Sitafloxacin.
Hydralazine
Oxatomide
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Oxatomide.
Hydralazine
Abexinostat
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Abexinostat.
Hydralazine
Mizolastine
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Mizolastine.
Hydralazine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Ricolinostat.